Exploring Congenital Hypopituitarism Through iPSC Models

Maria Andrea Camilletti, PhD, presents her personal and professional journey into pituitary research, detailing how family influences directed her interests towards this pivotal area of endocrinology. Growing up in a family where scientific inquiry was encouraged—her mother a biochemist and her grandfather and uncle in agronomy and engineering—Camilletti's early curiosity about science was cultivated by these familial figures who introduced her to the life sciences.

In 2007, she commenced her biological sciences education at the Faculty of Natural and Exact Sciences of the University of Buenos Aires (UBA), a distinguished institution in Argentina. The University’s vibrant environment, complemented by dedicated professors who were active in research, profoundly inspired her. In 2011, she began her focused journey in pituitary research by joining Graciela Díaz’s lab at the Institute of Biology and Experimental Medicine (IBYME) for a student fellowship.

Díaz was establishing her independent career, and through her guidance, Camilletti delved into the complexities of neuroendocrinology while also navigating the economic challenges associated with doing science in Argentina. This experience heightened her fascination with the pituitary gland, a small but crucial gland at the brain's base, controlling essential body functions such as reproduction, growth, behavior, metabolism, and homeostasis.

Reflecting on her time in the lab, Camilletti mentioned, "Immersing myself in bioinformatics and clinical genomics was both a challenging and rewarding experience. Working with patient data allowed me to exchange research findings with renowned experts and physicians managing pituitary disorders across various hospitals in Argentina." As an assistant researcher in the Laboratorio de Investigaciones Aplicadas en Neurociencias (LIAN) at Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) in Buenos Aires, her focus on pituitary research remained steadfast after completing her PhD.

She transitioned to the lab of María Inés Pérez Millán, a promising researcher who had recently established her laboratory in Buenos Aires following a six-year postdoctoral stint at the University of Michigan. Camilletti’s postdoctoral project aimed at creating a multigene panel for congenital hypopituitarism (CH), a multifaceted genetic disorder manifested by insufficient production of one or more pituitary hormones. The focus was on improving the molecular diagnosis of CH by identifying gene-specific variants.

Through her research, which involved screening over 170 pediatric patients for genetic alterations with a custom sequencing panel, Camilletti and her team successfully resolved around 15.3% of sporadic cases. However, many variants were deemed uncertain in significance (VUS), suggesting that additional functional assays would be required to clearly elucidate any pathogenic mechanisms.

Recognizing the need for innovative approaches to tackle new questions in the field, Camilletti’s team pivoted to utilizing induced pluripotent stem cell (iPSC) technology, a powerful model for disease exploration. This technology was first realized through pioneering efforts by Shinya Yamanaka and Kazutoshi Takahashi in 2006 and has significantly impacted medical research. iPSCs can self-renew and differentiate into various cell types, including endocrine cells, without the ethical complications typically linked to embryonic stem cells.

Camilletti’s current research endeavors aim to enhance understanding of congenital hormonal deficiencies by establishing iPSC-based in vitro models. This includes generating an iPSC line from a patient diagnosed with growth hormone (GH) deficiency and craniofacial anomalies, who possesses a novel heterozygous nonsense variant in the FOXA2 gene.

This gene is poorly characterized within hormonal disease contexts, and its role in pituitary development remains largely unexplored. Camilletti collaborates with specialists from Garrahan Hospital and the Faculty of Natural and Exact Sciences to model this disease accurately. Future steps involve deriving pituitary cells from the iPSCs and comparing these cells with control iPSCs to study the effects of the FOXA2 variant on clinical phenotypes.

Hoping her research will aid in enhancing diagnostic accuracy and genetic counseling, Camilletti noted, "Induced pluripotent stem cell technologies possess the potential for modeling hormonal deficiencies and may pave the way for cell transplantation therapies targeting hypopituitarism, thus opening new avenues for personalized medical strategies." She also plans to create a FOXA2 knockout iPSC line using gene-edited techniques to analyze the gene's role in pituitary differentiation and understand its transcriptional regulatory framework during this developmental process.

The allure of laboratory work is palpable in Camilletti’s reflections, where she shares the satisfaction derived from culturing iPSCs despite the procedural challenges involved, emphasizing the importance of creating contamination-free environments: "As a lab mate often mentions, one has to evolve into a kind of 'ninja-culture technician.'" Teaching and mentoring new PhD students also adds to her enthusiasm, particularly during discussions about scientific findings and when presenting at broader conferences.

Ultimately, Camilletti expresses her desire for her research to contribute meaningfully to the community by providing improved diagnostic tools, genetic counseling, and future treatment modalities for patients and their families. In her role at LIAN, she continues to pursue the potential of iPSC technologies and explore their implications for fostering innovative, personalized therapies to combat hormonal deficiencies.